Rosene Anesthesia Associates Inc Georgetown, MA - 01833

Rosene Anesthesia Associates Inc is categorized under Anesthesiologists in Georgetown, MA and active since 2001.

Rosene Anesthesia Associates Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Anesthesiologists business, which does work in the B2C market, and is classified as a Anesthesiologists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Philip Rosene at the company’s single location by writing to 8 Baldpate Road, Georgetown, Massachusetts MA 01833 or by phoning (978) 352-6395. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Rosene Anesthesia Associates Inc
Contact Person: Philip Rosene
Address: 8 Baldpate Road, Georgetown, Massachusetts 01833
Phone Number: (978) 352-6395
Annual Revenue (USD): $100.000 to $499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Anesthesiologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Rosene Anesthesia Associates Inc was started in 2001 to provide professional Anesthesiologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Philip Rosene for inquiries that concern Rosene Anesthesia Associates Inc by calling the company number (978) 352-6395, as your correspondence is most welcome. Additionally, the physical location of the single location of Rosene Anesthesia Associates Inc can be found at the coordinates 42.719213,-71.005822 as well as the street address 8 Baldpate Road in Georgetown, Massachusetts 01833.

For its online presence, you may visit Rosene Anesthesia Associates Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.